1. Home
  2. STXS vs BHST Comparison

STXS vs BHST Comparison

Compare STXS & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • BHST
  • Stock Information
  • Founded
  • STXS 1990
  • BHST 2007
  • Country
  • STXS United States
  • BHST Canada
  • Employees
  • STXS N/A
  • BHST N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • BHST
  • Sector
  • STXS Health Care
  • BHST
  • Exchange
  • STXS Nasdaq
  • BHST Nasdaq
  • Market Cap
  • STXS 151.3M
  • BHST 128.4M
  • IPO Year
  • STXS 2004
  • BHST N/A
  • Fundamental
  • Price
  • STXS $2.48
  • BHST $8.88
  • Analyst Decision
  • STXS
  • BHST Strong Buy
  • Analyst Count
  • STXS 0
  • BHST 2
  • Target Price
  • STXS N/A
  • BHST $13.00
  • AVG Volume (30 Days)
  • STXS 712.8K
  • BHST 11.3K
  • Earning Date
  • STXS 08-07-2025
  • BHST 08-11-2025
  • Dividend Yield
  • STXS N/A
  • BHST N/A
  • EPS Growth
  • STXS N/A
  • BHST N/A
  • EPS
  • STXS N/A
  • BHST N/A
  • Revenue
  • STXS $31,806,000.00
  • BHST $27,704,000.00
  • Revenue This Year
  • STXS $29.03
  • BHST $116.40
  • Revenue Next Year
  • STXS $44.05
  • BHST $55.91
  • P/E Ratio
  • STXS N/A
  • BHST N/A
  • Revenue Growth
  • STXS 33.94
  • BHST 74.76
  • 52 Week Low
  • STXS $1.54
  • BHST $4.66
  • 52 Week High
  • STXS $2.72
  • BHST $9.50
  • Technical
  • Relative Strength Index (RSI)
  • STXS 59.23
  • BHST N/A
  • Support Level
  • STXS $2.18
  • BHST N/A
  • Resistance Level
  • STXS $2.67
  • BHST N/A
  • Average True Range (ATR)
  • STXS 0.14
  • BHST 0.00
  • MACD
  • STXS -0.00
  • BHST 0.00
  • Stochastic Oscillator
  • STXS 66.07
  • BHST 0.00

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: